News

Antimicrobial drug developer HOOKIPA Pharma (NASDAQ:HOOK) announced Thursday that Gilead Sciences (NASDAQ:GILD) has agreed to ...
Gilead Sciences is paying $10 million for sole ownership of arenavirus immunotherapies for hepatitis B (HBV) and HIV ...
The stock's fall snapped a four-day winning streak.
Shares of Gilead Sciences Inc. advanced 3.57% to $106.16 Monday, on what proved to be an all-around great trading session for ...
Josh Charles, Elisabeth Moss, costume designer Leslie Kavanagh and production designer Elisabeth Williams also speak to The ...
The end is almost here for the heroes and villains of Gilead and beyond. The penultimate episode "Execution" not only lives ...